Entity Type
Company
Filer Snapshot
Gem Pharmaceuticals LLC
CIK 0001727356. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total Filings
3
Latest Filing
07 Feb 2025
Industry
n/a
Follow future filing-backed changes
Save this filer to return when a new filing changes the portfolio, large-stake, insider, or company context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Best next click
Start with the summary below, then verify the strongest source-backed page for this filer.
- Open 13F if you want portfolio holdings.
- Open 13D/G or insider pages only when this CIK has those rows.
Source: SEC Schedule 13D/G
View Source Filing
SCHEDULE 13D/A filed on 07 Feb 2025 for CIK 0001727356.
- Business address
- 200 Randolph Avenue, Hunstville, AL, 35801
- State of incorporation
- AL
- Fiscal year end
- 31 December
Filer intelligence
What SEC filings say about Gem Pharmaceuticals LLC
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
13F portfolio
No rows yet
Quarterly institutional portfolio holdings.
13D/G stakes
No rows yet
Beneficial ownership and large-stake disclosures.
Forms 3/4/5
No rows yet
Officer, director, and 10% owner holdings or transactions.
No parsed ownership summary yet
We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.
SEC filing record
CIK 0001727356 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
3
First seen
08 Jan 2018
Latest filing
07 Feb 2025
Entity
Company
Observed form types
SCHEDULE 13D/A
SC 13D
3
Primary evidence
Latest Filings
Recent SEC filings for Gem Pharmaceuticals LLC with direct links to document and filing folders.
SCHEDULE 13D/A
File 005-91259
SCHEDULE 13D/A filing
- Filing date
- 07 Feb 2025
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D
File 005-91259
PRIMARY DOCUMENT
- Filing date
- 23 Dec 2019
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
File 000-55866
PRIMARY DOCUMENT
- Filing date
- 08 Jan 2018
- Reporting date
- 08 Jan 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing